Purchase Price Allocation in Acquisitions

When one company buys another, purchase price allocation in acquisitions is the disciplined process of assigning the total deal price to every identifiable asset and liability at fair value, with any shortfall becoming goodwill. This allocation is not negotiable—it follows ASC 805 (US GAAP) or IFRS 3 (international), and it shapes the acquirer’s balance sheet and future earnings for years.

Why Acquisition Price ≠ Goodwill

Acquirers rarely pay a price equal to the book value of a target’s assets minus liabilities. If the purchase price is $500 million and the target’s book equity is $300 million, the $200 million premium does not all become goodwill. Some of it—often the majority—belongs to specific assets (patents, customer lists, real estate) and liabilities (deferred revenue, pension obligations) that the acquirer is stepping into. Only after assigning fair value to every identifiable item does the residual become goodwill.

Consider a purchase of a SaaS company for $100 million. The balance sheet shows $30 million in cash, $20 million in receivables, $10 million in software development costs (capitalized), and $5 million in liabilities. Under book value, equity is $55 million. The $45 million premium cannot be labeled goodwill immediately. An appraisal might reveal that the customer contracts (not on the balance sheet) have a fair value of $25 million, and the proprietary algorithm (internally developed) is worth $15 million. Only the remaining $5 million is goodwill. This reallocation is not optional—ASC 805 demands it.

The Measurement Process: The Four Steps

The acquisition purchase price is allocated in a defined order, following the acquisition-method framework:

1. Identify and list identifiable assets and liabilities. The acquirer’s valuation team catalogs every tangible and intangible asset the target owns and every obligation it owes. Tangible items include real property, equipment, and inventory. Intangible items include customer relationships, trade names, patents, software, non-compete covenants, and leases.

2. Assign fair values to each. For each item, the acquirer determines fair value—the price that would be paid in an arm’s-length transaction. Real estate is appraised; customer contracts are analyzed for renewal rates and margins; in-process R&D is valued using a discount-rate model. Liabilities are also revalued: pension obligations are actuarially re-measured; deferred revenue is marked to estimated fulfillment cost; contingent consideration (earnout payments) is discounted to present value.

3. Sum the fair values of identifiable net assets. Add all asset fair values, subtract all liability fair values.

4. Calculate residual goodwill. Goodwill = Purchase Price − (Fair Value of Identifiable Net Assets). If the identifiable assets exceed the purchase price, the result is a “bargain purchase gain,” recorded as income.

The entire allocation process must be finalized within 12 months of close under US GAAP (though the acquirer can report provisional figures initially and refine them during the measurement period).

Intangible Assets: The Hidden Bulk of PPA

In most acquisitions of profitable companies, intangible assets absorb the lion’s share of the premium. A strategic buyer of a mature business with a strong brand, loyal customer base, and efficient supply chain is paying primarily for intangibles—things the balance sheet does not list as assets.

The most common intangible items are:

• Customer relationships and contracts: If the target has long-term contracts with recurring revenue and high retention, these are valued separately from goodwill. Fair value is typically estimated as the present value of margin on renewal revenue.
• Trade names and trademarks: If the brand is recognizable and defensible, it receives a standalone valuation, often using a “relief-from-royalty” method (the value of not having to pay a royalty to license a similar brand).
• Developed technology and patents: Existing patents, software, and manufacturing processes are appraised using income-approach methods, often involving discounted licensing fees or cost-savings analysis.
• In-process R&D: If the target has half-built products or ongoing trials, these are valued and capitalized (not expensed immediately), then amortized over their expected useful life or until impairment.
• Assembled workforce and non-compete agreements: The value attributable to trained, in-place employees is sometimes recognized as an intangible asset, distinct from goodwill. Non-compete covenants signed by key employees receive a standalone valuation.
• Goodwill (residual): The portion of purchase price that cannot be attributed to any specific identifiable asset or liability.

Each intangible asset receives its own estimated useful life for amortization. A customer relationship might be amortized over 10 years; a patent over its remaining legal life; a trade name over 20 years (or indefinitely if renewal is assured and cost is negligible).

Contingent Consideration and Earnouts

If part of the purchase price is contingent—for example, the acquirer will pay a $50 million earnout if the target hits revenue targets in year 2—that earnout is included in the purchase price at its fair value. Fair value of an earnout is typically estimated by probability-weighting the possible payout scenarios and discounting to present value. If there is a 60% chance the earnout will be paid in full ($50M) and a 40% chance it will be zero, the fair value is $30 million (0.6 × $50M), and that $30 million is included in the purchase price for PPA purposes.

If the earnout is later revised (because actual results differ from expectations), the adjustment flows through goodwill under US GAAP, not the gain or loss on the acquisition.

Deferred Taxes and Other Liabilities

The fair-value measurement includes assumptions about future tax liability. If the target owns assets with a stepped-up fair value but no equivalent tax step-up (because a Section 338(h)(10) election was not made), the acquirer recognizes a deferred tax liability for the future tax on the inherent gain. This deferred tax liability is part of the measured liabilities and reduces the goodwill that would otherwise be recognized.

Conversely, if the target has a loss carryforward or other tax attribute, the valuation of that attribute (discounted for uncertainty) becomes part of the identifiable assets, reducing goodwill.

Common Pitfalls and Judgment Calls

Valuing intangible assets is not scientific; it requires reasonable estimates and defensible assumptions. The SEC and auditors scrutinize PPAs, particularly when:

• Intangibles are too large: If 80% of the purchase price is assigned to indefinite-life intangibles (like goodwill or trade names), impairment risk is high if future cash flows disappoint.
• Fair values are borrowed from third-party reports without independent assessment: Acquirers must take ownership of the valuation, not merely rely on the target’s estimates.
• Useful lives are implausibly long: Assigning a 30-year life to in-process R&D in a fast-changing industry invites questions.
• Contingencies are underpriced: Earnouts and contingent liabilities must reflect genuine probability, not optimistic scenarios.

The Link to Impairment Testing

Goodwill is not amortized under US GAAP and IFRS 3, but it must be tested annually (or when indicators suggest impairment) by comparing the carrying value to the fair value of the reporting unit to which it is assigned. If the carrying value exceeds fair value, goodwill is impaired and written down. This is why a well-documented PPA is essential: the allocation establishes the baseline goodwill figure that will be monitored for the life of the acquisition.

See also